Get a Quote

Solriamfetol Hydrochloride
CAS NO.: 178429-65-7
Chemical Formula: C10H15ClN2O2
Molecular Weight: 230.6900
DMF&GMP status: Please contact us for more details.
Description:
Solriamfetol marketed under the brand name Sunosi by Jazz Pharmaceuticals in the United States is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated in treating daytime sleepiness associated with narcolepsy or obstructive sleep apnea. Solriamfetol was given FDA approval in 2019.

**The products protected by patents in this product catalog are used for laboratory analysis, research and development, and cannot be sold to any country or region with patent protection and for commercial purpose. If the resulting patent infringement risks and responsibilities will be borne by the buyer.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
SOLRIAMFETOL HYDROCHLORIDETABLET;ORALEQ 75MG BASESUNOSIJAZZ PHARMACEUTICALS IRELAND LTD
SOLRIAMFETOL HYDROCHLORIDETABLET;ORALEQ 150MG BASESUNOSIJAZZ PHARMACEUTICALS IRELAND LTD
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
844071508/25/2027U-2548
887780606/07/2026U-2548
960491706/07/2026U-2548
1019515109/05/2037DP
1035151706/07/2026U-2548
1051260909/05/2037U-2548
Exclusive Data
Exclusivity Code Exclusivity Expiration
NCE 06/17/2024
ODE-254 06/17/2026